Protalix BioTherapeutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026
Revenue % change YoY	$38.35M N/A	$47.63M 24.21%	$65.49M 37.48%	Avg: $101.4M Low: $101.4M High: $101.4M avg. 54.82%	Avg: $167.2M Low: $167.2M High: $167.2M avg. 64.89%
Net Income % change YoY	$-33.98M N/A	$-14.92M 56.07%	$8.31M 155.68%	Avg: $54.59M Low: $51.92M High: $51.92M avg. 556.80%	Avg: $99.88M Low: $93.13M High: $93.13M avg. 82.96%
EBITDA % change YoY	$-20.06M N/A	$-10.78M 46.25%	$11.65M 208.05%	Avg: $-13.79M Low: $-13.79M High: $-13.79M avg. -218.43%	Avg: $-22.75M Low: $-22.75M High: $-22.75M avg. -64.89%
EPS % change YoY	-$0.77 N/A	-$0.31 59.74%	$0.12 138.70%	Avg: $0.63 Low: $0.63 High: $0.63 avg. 425%	Avg: $1.13 Low: $1.13 High: $1.13 avg. 79.36%
Operating Expenses % change YoY	$42.46M N/A	$41.06M -3.30%	$32.05M -21.93%	Avg: $23.61M Low: $23.61M High: $23.61M avg. -26.32%	Avg: $38.93M Low: $38.93M High: $38.93M avg. 64.89%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 319.88% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is 51.92M, average is 54.59M and high is 51.92M.

Wall Street analysts forecast annual average revenue growth of 59.85% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $101.4M, average is $101.4M and high is $101.4M.

Wall Street analysts forecast annual average earnings growth of 252.18% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is $0.63, average is $0.63 and high is $0.63.